- Home
- AX vs GH Comparison
AX vs GH Comparison
Compare AX & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AX
- GH
- Stock Information
- Founded
- AX 1999
- GH 2011
- Country
- AX United States
- GH United States
- Employees
- AX N/A
- GH N/A
- Industry
- AX Savings Institutions
- GH Medical Specialities
- Sector
- AX Finance
- GH Health Care
- Exchange
- AX Nasdaq
- GH Nasdaq
- Market Cap
- AX 4.1B
- GH 4.3B
- IPO Year
- AX 2005
- GH 2018
- Fundamental
- Price
- AX $68.95
- GH $37.46
- Analyst Decision
- AX Buy
- GH Strong Buy
- Analyst Count
- AX 5
- GH 14
- Target Price
- AX $83.20
- GH $39.93
- AVG Volume (30 Days)
- AX 446.3K
- GH 1.8M
- Earning Date
- AX 01-28-2025
- GH 02-20-2025
- Dividend Yield
- AX N/A
- GH N/A
- EPS Growth
- AX 50.08
- GH N/A
- EPS
- AX 8.22
- GH N/A
- Revenue
- AX $1,127,187,000.00
- GH $692,256,000.00
- Revenue This Year
- AX N/A
- GH $32.21
- Revenue Next Year
- AX $5.84
- GH $16.90
- P/E Ratio
- AX $8.38
- GH N/A
- Revenue Growth
- AX 22.64
- GH 29.20
- 52 Week Low
- AX $44.10
- GH $15.81
- 52 Week High
- AX $88.46
- GH $39.29
- Technical
- Relative Strength Index (RSI)
- AX 38.89
- GH 66.67
- Support Level
- AX $65.66
- GH $34.80
- Resistance Level
- AX $72.33
- GH $37.46
- Average True Range (ATR)
- AX 1.93
- GH 1.78
- MACD
- AX -0.29
- GH 0.51
- Stochastic Oscillator
- AX 46.27
- GH 80.49
About AX Axos Financial Inc.
Axos Financial Inc is a bank holding company that operates through its bank subsidiary, BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small to medium-size businesses in certain sectors, and selected specialty finance receivables. Its operating segments are banking business segment and securities business segment . The bank distributed its products through a wide range of retail distribution channels, including only banking brands, affinity groups, and sales teams, among others. The majority of the bank's mortgage exposure is titled toward the state of California, particularly its southern region. Net interest income is a majority of the bank's revenue.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.